Oil India shares have a 41% upside potential, Avendus Spark says citing strong earnings

Out of the 21 analysts that have coverage on Oil India, 17 of them have a “buy” rating on the stock, while two each have a “hold” and “sell” recommendation.

Out of the 21 analysts that have coverage on Oil India, 17 of them have a “buy” rating on the stock, while two each have a “hold” and “sell” recommendation.

Anand Shah, CIO of PMS and AIF Investments at ICICI Prudential AMC, remains underweight on product-centric segments such as FMCG, consumer durables, and, to some extent, the automobile sector.

Gaurav Malhotra, Executive Director at Axis Capital, said the government’s move asking public sector undertakings (PSUs) to use BSNL and MTNL for telecom services is unlikely to have any significant impact on private operators.

Rekha Jhunjhunwala sold 17.38 lakh shares or 1.98% of Nazara Technologies’ outstanding equity between June 2 and June 6.

Talbros Automotive Share Price | The company received orders worth ₹260 crore (including 1₹50 crore of exports, majorly in Europe) which include ₹180 crore for sealing business of gaskets and heat shield products and ₹80 crore forgings products.

According to Prime Database, the IPO pipeline is now larger than ever. A total of 72 companies have already received SEBI clearance for IPOs. These approvals represent a potential fundraising of ₹1.4 lakh crore.

Prashant Paroda, Portfolio Manager Emerging Markets at Allspring Global Investments said that Indian banks and financials, which had lagged over the past few years, are now showing signs of a strong catch-up trade.

Overall, HSBC expects total APE growth to be between 14% and 17% in financial year 2026 for stocks under its coverage.

Life Insurance Corporation of India (LIC), India’s largest insurance company has been issued half or 50% of total number of shares approved under the QIP. Societe Generale, Morgan Stanley and Vikasa India EIF I Fund have also been issued more…

As of the March-end quarter, OrbiMed Asia IV Mauritius FVCI Ltd had a 10.88% stake in Marksans Pharma.